Streamlined Clinical Development Strategies
Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.
Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process.
A recent review (DOI: 10.1177/1740774518820060) includes 288 articles, including 132 of patient management and accrual costs and 118 on infrastructure costs. 254 reports suggest that operational efficiencies and patient accrual, 33% and 24% articles, are essential to reducing trial costs.
Review findings: 1) delayed trial activation costs budgets; 2) poor accrual leads to low-value trials and wasted resources.
The sponsor who hires third-party experts, like BBCR Consulting, with proficiency in streamlining clinical trials and aligning goals, eliminates any unnecessary waste of resources.
Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.